N-((1S)-1-{[((1S)-3-Hydroxy-2-oxo-1-{[(3S)-2-oxopyrrolidin-3-yl]-methyl}propyl)amino]carbonyl}pentyl)-4-methoxy-1H-indole-2-carboxamide

ID: ALA4754028

PubChem CID: 154702364

Max Phase: Preclinical

Molecular Formula: C24H32N4O6

Molecular Weight: 472.54

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCC[C@H](NC(=O)c1cc2c(OC)cccc2[nH]1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO

Standard InChI:  InChI=1S/C24H32N4O6/c1-3-4-6-17(23(32)28-18(20(30)13-29)11-14-9-10-25-22(14)31)27-24(33)19-12-15-16(26-19)7-5-8-21(15)34-2/h5,7-8,12,14,17-18,26,29H,3-4,6,9-11,13H2,1-2H3,(H,25,31)(H,27,33)(H,28,32)/t14-,17-,18-/m0/s1

Standard InChI Key:  VBDNWOQWUMJPAC-WBAXXEDZSA-N

Molfile:  

 
     RDKit          2D

 35 37  0  0  0  0  0  0  0  0999 V2000
   18.2948   -7.4780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7117   -8.1874    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.7033   -6.7638    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.5247   -6.7589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9291   -6.0447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9374   -7.4684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7587   -7.4635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1756   -8.1729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7504   -6.0399    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.5163   -5.3353    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.1589   -5.3257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9802   -5.3208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3846   -4.6066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3930   -6.0302    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.7420   -4.6162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1505   -3.9020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9642   -3.8147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1294   -3.0102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4151   -2.6058    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.8071   -3.1563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0022   -2.9929    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.3266   -3.8961    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   23.2059   -4.6018    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.4735   -7.4828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9887   -6.8240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9965   -8.1528    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.2139   -7.9038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2130   -7.0843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5040   -6.6770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7954   -7.0882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8002   -7.9108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5098   -8.3143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5022   -5.8599    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.7936   -5.4528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9928   -8.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  6
  6  7  1  0
  7  8  1  0
  5  9  1  0
  5 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 11 15  1  1
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 16  1  0
 20 21  2  0
 16 22  1  6
 13 23  1  0
  1 24  1  0
 24 25  2  0
 25 28  1  0
 27 26  1  0
 26 24  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 27  1  0
 29 33  1  0
 33 34  1  0
  8 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4754028

    ---

Associated Targets(non-human)

SARS-CoV (424 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 472.54Molecular Weight (Monoisotopic): 472.2322AlogP: 1.04#Rotatable Bonds: 12
Polar Surface Area: 149.62Molecular Species: NEUTRALHBA: 6HBD: 5
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 12.46CX Basic pKa: CX LogP: 0.48CX LogD: 0.48
Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.31Np Likeness Score: 0.30

References

1. Hoffman RL,Kania RS,Brothers MA,Davies JF,Ferre RA,Gajiwala KS,He M,Hogan RJ,Kozminski K,Li LY,Lockner JW,Lou J,Marra MT,Mitchell LJ,Murray BW,Nieman JA,Noell S,Planken SP,Rowe T,Ryan K,Smith GJ,Solowiej JE,Steppan CM,Taggart B.  (2020)  Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19.,  63  (21): [PMID:33054210] [10.1021/acs.jmedchem.0c01063]

Source